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ABSTRACT 
Objective: Studies have shown that prolonged physical exercise increases ventricular wall mass. Physiologically, this increase is followed by an 
increase of mitochondrial biogenesis. However, increases of ventricular mass in some cardiovascular diseases are not followed by an increase of 
PPARγ coactivator-1α (PGC-1α), a marker of mitochondrial biogenesis. No data regarding cardiac PGC-1α during an excessive physical exercise 
program that causes pathological conditions (overtraining) are available. Thus, we aimed to determine the effect of overtraining on cardiac 
hypertrophy index and PGC-1α level. Furthermore, we aimed to elucidate the cardio protective effect of Hibiscus sabdariffa Linn. (HSL) 
administration on these cardiac parameters.  
Methods: Twenty-five male adult Wistar rats aged 8–10 w were randomly divided into five groups: control (C), control-HSL (C-HSL), aerobic training 
(A), overtraining (OT), and overtraining-HSL (OT-HSL). Treatments were conducted five times a week, for 11 w. Differences in heart mass were 
determined by measuring ratios of ventricular weight to body weight (hypertrophy index). PGC-1α levels were measured using an ELISA method. 
Results: We found that overtraining increased ventricular wall mass; however, it did not increase cardiac PGC-1α levels, whereas mild-aerobic 
exercise robustly increased cardiac levels of PGC-1α. Furthermore, administration of a methanol extract of HSL did not show any significant effect 
on cardiac mass or PGC-1α level.  
Conclusion: Thus, our study showed that ventricular hypertrophy elicited by overtraining conditions was not followed by an increase in cardiac 
PGC-1α, and administration of H. sabdariffa extract did not ameliorate this condition.  
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INTRODUCTION 
The purpose of physical training, by and large, is to enhance physical 
performance. At whatever point the power, length, and 
repetitiveness of work begin to burden proper body function, 
physiological adjustments occur. Successful sports athletes are often 
faced with long-term training, especially when preparing for a 
match, that frequently causes a condition called overtraining (OT). 
OT can be characterized as an increase in exercise intensity that 
results in a significant loss of diminished achievement or described 
performance of the sport, and can be associated with mood 
disturbance. Endless resistance exercise can result in various 
reactions to OT contingent upon either training duration or 
excessive power exertion [1]. 
Physiologically, an increase in the workload of the heart during long-
term physical exercise can lead to cardiac adaptation that causes 
structural and functional changes in heart tissue. Such physiological 
adaptations to environmental conditions can cause the heart to grow or 
shrink. In OT, physiological adaptation is expected to become delayed or 
even produce a pathological adaptation of the cardiovascular system. 
The heart can increase in size depending on the type, power, and 
duration of stimulation, resulting in physiological or pathological 
hypertrophy [2]. The heart can also incrementally decrease in size 
contingent upon the type, quality, and length of incitement that brings 
about physiological or neurotic hypertrophy [2]. 
Hypertension is related to unfavorable morphological and functional 
changes in the cardiovascular framework, including left ventricular 
hypertrophy (LVH). Epidemiological examinations demonstrate that 
prevalence of LVH in Chinese patients with basic hypertension was 
about 25% to 35%. LVH is viewed as a free hazard factor for 
cardiovascular disorders and heart failure [3]. Physiological 
hypertrophy is characterized by normal or enhanced contractile 
function coupled with normal architecture and organization of cardiac 
structure. Pathological hypertrophy is associated with increased 
cardiomyocyte death and fibrotic remodeling, and is characterized 
clinically by reduced systolic and diastolic function that often 
progresses towards heart failure [2]. As a macroscopic result, 
morphometric methods are needed whenever there is the necessity to 
describe and compare shapes of organisms or particular structures 
within living beings, including to assess changes in heart size [4].  
Heart workload requires more ATP to maintain cardiac contractility, 
there is evidence that contractility disorders can be at risk for heart 
failure. The past decade has seen a resurgence of enthusiasm for heart 
mediators, as well as enormous advances in our comprehension of 
transcriptional systems that direct cardiovascular energetics. The 
dynamic range of cardiac activity is large, either exercise (acutely), and 
development, especially postnatal (chronically). As such, bioenergetic 
programs in the heart should be firmly controlled along these lines. 
PPARγ coactivator-1α (PGC-1α), whose expression and action are 
perfectly attuned to extracellular and physiologic signals, assumes a focal 
job in these pathways. For example, at the gene expression level, PGC-1α 
is stimulated in liver and heart by fasting, brown fat by cold-induced 
sympathetic stimulation, and skeletal muscle and heart by exercise [6]. 
The results of research conducted by Finck (2007), indicate that PGC-1α 
plays an important role in controlling cardiac energy metabolism and 
suggest that perturbations in the PGC-1α system could influence to 
cardiomyopathic remodeling. PGC-1α overexpression prevented cardiac 
hypertrophy or improved contractility in cultured cardiac myocytes [7]. 
Moreover, a study by Pereira et al. (2014) showed that PGC-1α is 
repressed in concert with reduced mitochondrial oxidative capacity and 
fatty acid oxidation (FAO) during pathological hypertrophy [8]. 
Hibiscus sabdariffa Linn. (HSL), or roselle, is an herbal plant used for 
cancer prevention, controlling blood pressure, and improving bowel 
movements. The most important ingredients in roselle flower are 
gassypetin, glucoside hibiscin, and anthocyanin–an antioxidant and 
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natural pigment that gives roselle infusion its red color. High levels 
of antioxidants in roselle petals can inhibit free radicals. These 
substances are believed to function as diuretics, reduce blood 
viscosity and blood pressure, and stimulate intestinal movements 
[9]. In the literature, only one previous study focused on the direct 
effects of anthocyanins to prevent cardiovascular disease [10]. 
Understanding the effects of OT on various organs is useful for 
determining amounts of exercise for athletes and approaches 
needed to reduce the risk of OT, for example by using the herbal 
supplement HSL. There is currently no research on the effects of 
overtraining on PGC-1α levels and cardiac mass changes in the heart, 
nor the potential related effects of HSL. Therefore, this study 
examined the effects of OT on PGC-1α levels and hypertrophy index 
changes in the heart, as well as the effects of HSL. 
MATERIALS AND METHODS 
Animals 
Male Wistar rats (Rattus norvegicus), aged 8–11 w and with body 
weights ranging from 200–250 g were purchased from Faculty of Animal 
Science at the Institute Pertanian Bogor (Bogor, Indonesia). Animals 
were randomly divided into five groups: control (C, sedentary rat 
administered placebo), control-HSL (C-HSL, sedentary rat administered 
H. sabdariffa extract), aerobic training (A, subjected to aerobic program 
and administered placebo), OT (subjected to OT program and 
administered placebo), and OT-HSL (subjected to OT program and 
administered H. sabdariffa extract). Exercise was conducted 5 times a 
week, for 11 w. Rats were maintained on a 12-h light/dark cycle, with 
free access to food and water. All efforts were made to maintain animal 
welfare. Approval for this study was obtained from the Ethics Committee 
of Medical Research-Faculty of Medicine Universitas Indonesia/Cipto 
Mangunkusumo Hospital (FMUI/RSCM) No: 0955/UN2. F1/ETIK/2018. 
Extract 
Methanolic extract of Hibiscus sabdariffa L. was obtained from Pusat 
Studi Biofarmaka (PSB)-Institut Pertanian Bogor. Extract of Hibiscus 
sabdariffa L. was extracted from its calyxes. Administration of this 
extract was performed orally with a dose of 500 mg/kg, five times a 
week for 11 w, three hours before physical exercise training.  
Physical exercise protocol: overtraining and aerobic programs 
Rats underwent acclimatization for two weeks before commencing 
physical exercise programs. Rats that met inclusion criteria were 
acclimated to running on the treadmill during an adaptation procedure.  
Overtraining program 
The OT program corresponded to a protocol developed by Hohl [5]. The 
duration of the program was 11 w. First, rats underwent an adaptive 
phase of running five times a week for 4 w, with 24-h recovery time. This 
phase started with low-speed and short-duration running (10 m/min for 
10 min) which was progressively increased every week until the velocity 
and duration reached 20 m/min for 60 min. Then, OT rats we submitted 
to a second adaptive phase for another 4 w. During this phase, the 
velocity and duration was fixed at 20 m/min and 60 min to adapt mice to 
a stable training load. For the last 3 w, the frequency of daily exercise 
sessions was increased to two-, three-, and four-fold followed by a 
reduction of recovery time between training sessions (4 h, 3 h, and 2 h, 
respectively) to create an imbalance between overload and recovery. 
The duration of running was measured manually using a stopwatch. 
Aerobic exercise program 
Rats that underwent the aerobic program were exercised on the 
treadmill with a constant velocity and duration twice a week for 11 
w. The dose of running corresponded to aerobic exercise (i.e. 12 
m/min for 10 min for each session).  
Measurement of body weight, cardiac hypertrophy, and PGC-1α level 
Twenty-four hours after the last training session, rats were sacrificed. 
Prior to sacrificing, body weights of rats were obtained. Hearts were 
removed from the mediastinum and aorta of each rat and all epicardial 
fats were carefully removed. Hearts were rinsed in phosphate-buffered 
saline (0.01M, pH 7.2–7.4) to remove excess blood. The heart was wiped 
with a towel and weighed as a whole heart measurement. Next, the 
atrium was removed and the remaining portion was measured as the 
ventricular weight. Subsequently, the left and right ventricles were 
separated by tracing the anterior and posterior longitudinal sulcus. The 
left ventricle, including the interventricular septum, was measured to 
determine left ventricular weight. A Ventricular Hypertrophy Index 
(VHI) was determined by the proportion of ventricular weight/body 
weight, while a Left Ventricular Hypertrophy Index (LVHI) was 
determined by the proportion of left ventricular weight/body weight. 
Both ratios are presented as percentages. 
Heart tissues were then homogenized and analyzed for PGC1-α 
levels according to the manufacturer’s instructions for the PGC1-α 
ELISA kit (CUSABIO, Wuhan, China).  
Statistics 
Data processing was performed using Prism 6.0 software (GraphPad, 
San Diego, CA). Body weight, VHI, and LVHI were evaluated with one-
way ANOVA test followed by Tukey post hoc analyses to account for 
multiple comparisons between groups. Data were previously analyzed 
for normality with a Kolmogorov Smirnov test. All data are presented 
as means±standard error of the mean (SEM). For all comparisons, 
values of p<0.05 were considered significant. 
RESULTS 
Characteristic rat body weights among groups 
Rat body weights were obtained as one parameter for determining 
VHI and LVHI. Before starting the physical exercise program, rats 
were randomly divided such that there was no difference in rat body 
weights among groups (fig. S1).  
 
 
Fig. S1: Comparison of rat body weight among groups before 
intervention. There were no significant differences in rat body 
weights among groups. (Data represent mean±SEM; n = 5 
rats/group. One-way ANOVA) 
 
At the last training session, as expected, we found that OT rats 
(327±12.4 g) had lower body weights than rats in control (376.2±12.4 
g, p<0.01) or aerobic (415.4±12.4 g, P<0.001) groups (fig. 1).  
 
 
Fig. 1: Overtraining program caused a reduction of body weight, 
while administration of H. sabdariffa did not affect body weight, 
Overtraining condition rats had lower body weights compared with 
control and aerobic groups. Rats with aerobic exercise programs 
had the highest body weight among the groups. Administration of 
H. Sabdariffa had no effect on body weight in control or 
overtraining conditions. (Data represent mean±SEM; n = 5 
rats/group. *p<0.05, **p<0.01, ***p<0.005 one-way ANOVA 
followed by Tukey post hoc analysis) 
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Rats undergoing aerobic training had slightly higher body weights. 
Administration of HSL did not affect the body weight of rats in 
control (376.2±12.4 g vs 376.8±12.4 g with HSL) or OT (327±12.4 g 
vs 326.8±12.4 g with HSL) groups. Thus, our OT program caused a 
reduction of body weight, one symptom of OT syndromes, and 
administration of HSL did not affect body weight. 
Overtraining rats had increased cardiac mass compared with 
control and aerobic rats 
Physiologically, an increase in cardiac workload during long-term 
physical exercise can lead to structural and functional adaptations of 
the heart. To observe cardiac mass changes in the heart, we calculated 
ratios of ventricular weight/body weight and left ventricular 
weight/body weight (as percentages). We found that OT rats 
(0.268±0.01049) had the highest ratio of ventricle weight to body 
weight compared with control (0.232±0.0058, p<0.05) and aerobic 
(0.2252±0.0104, p<0.019) groups (fig. 2A). We also found ratios of left 
ventricular weight/body weight in OT rats (0.2172±0.01073) were 
higher than aerobic rats (0.1774±0.01073, p<0.05; fig. 2B). Altogether, 
our data indicate that cardiac morphometric changes occurred in the 
OT condition, specifically an increase of ventricular mass (particularly 
left ventricle) representative of hypertrophic ventricular conditions. 
 
 
Fig. 2: Overtrained rats had the highest ratios of ventricle weight to body weight (%) and left ventricle weight to body weight (%). 
Hibiscus sabdariffa L. administration did not affect ratios in control or overtraining groups. (A) Comparison of ratios of ventricle 
weight/body weight percentages among groups. (B) Comparison of ratios of left ventricle weight/body weight percentages among groups. 
(Data represent mean±SEM; n = 5 rats/group. *p<0.05, **p<0.01, one-way ANOVA and Tukey post hoc) 
 
Overtrained rats have lower levels of cardiac PGC-1α compared 
with aerobic rats 
One factor that mediates cardiac responses to training conditions is 
proliferator-activated gamma coactivator 1-alpha receptor (PGC-
1α), which is involved in mitochondrial biogenesis and metabolism 
in heart and skeletal muscle. In response to exercise training, PGC-
1α production increases with increasing mitochondrial function. Our 
results showed lower PGC-1α levels in OT rats (5.87±3.621) 
compared with aerobic-trained rats (23.79±3.621, p<0.005). Thus, 
with overtraining, the pathological hypertrophy that occurs 
suppresses PGC-1α levels in the heart. 
 
 
Fig. 3: Overtraining program did not increase cardiac levels of 
PGC-1α in contrast to an aerobic exercise program, nor did H. 
sabdariffa administration. Overtrained rats had lower 
concentrations of PGC-1α compared with others groups. 
Instead, the aerobic group had the highest concentration of 
PGC-1α. H. sabdariffa administration did not affect the 
concentration of PGC-1α in control or overtraining groups. 
(Data represent mean±SEM; n = 5 rats/group. **p<0.01, 
***p<0.005, one-way ANOVA and Tukey post hoc) 
 
DISCUSSION 
Physical training is performed to increment and enhance physical 
performance. Physiological adjustments occur based on the force, 
duration, and daily work burden. Physiological adaptation of the heart 
to environmental conditions can cause the heart to grow or shrink. 
However, there is a genuinely unobtrusive delimitation between an 
outstanding performance and a decline resulting from overtraining 
(OT). Symptoms of OT may include muscular weakness and lesion, 
cytosine initiation, hormonal and hematological adjustments, mood 
swings, psychological depression, and nutritional disorders. In view of 
the premise that OT results from an imbalance between training and 
recuperation, neuroendocrine disruption has been proposed as a 
fundamental mechanism underlying OT [1]. 
Rats were weighed every day throughout the course of treatment, from 
the first week to the eleventh. We attempted to compare differences 
between average body weights among the five study groups. Differences 
in body weight were assessed based on changes in initial body weight 
until the eleventh week. From the results shown in fig. 1, body weights in 
the aerobic group were higher than in control and OT groups. This is 
consistent with findings described in Sengupta et al. (2003) suggesting 
that in the age range until maturity, training results in musculoskeletal 
maturity and increased muscle mass [11].  
Fig. 1 also shows that weights of rats in the OT group were lower than in 
control and aerobic groups. Notably, this decrease was in line with 
Hohl's (2009) study indicating a natural decline in body weight in OT 
rats is a positive adaptation to physical exercise, although after reaching 
the eleventh week, weight continued to decline. Several studies have 
concluded that weight loss or loss of body mass can be used as a likely 
symptom or marker of OT in humans. According to Hohl (2009), this 
body weight decrease was related to hyper metabolism and proteolysis 
as a result of persistent physical workload [12]. 
Hypertrophy can be assessed functionally or anatomically, with an 
increase in heart mass being the most commonly assessed anatomical 
indicator. The simplest benchmark for assessing cardiac hypertrophy 
macroscopically is the weight of the heart and the left ventricle [13, 
14]. The heart can increase in size depending on the type, strength, 
and duration of stimulation, resulting in physiological or pathological 
cardiac hypertrophy [2]. Increasing cardiac work can cause high blood 
pressure that can increase heart burden and in the end can cause 
decreasing if cardiovascular system function, with the occurrence of 
pathological ventricular hypertrophy [3]. Ventricles are a part of the 
heart that is primarily hypertrophic, such that measurements of the 
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left ventricle are important benchmarks of an increase in cardiac mass 
[15]. Therefore, to determined cardiac hypertrophy, heart weight and 
left ventricle weight is also need to studied together with body weight 
and calculate the ratio and then the number of increased heart weight 
is obtained. The results of this study indicate that ratios of ventricular 
weight/body weight and left ventricular weight/body weight (fig. 2) 
are low in the OT rat group compared with other groups, indicating 
that OT leads to cardiac hypertrophy.  
PGC-1 is the key player in the mitochondrial biogenesis and metabolism 
in heart and skeletal muscle [12]. is important for mediating the 
cardioprotective effects of exercise and can be induced by integrators of 
transcriptional circuits that regulate mitochondrial function and 
biogenesis [16, 17]. PGC-1α expression is induced by physiological 
stimuli that increase ATP production and stimulate mitochondrial FAO, 
such as during meals, cold temperatures, and exercise. The results of this 
study showed increased PGC-1α levels in the aerobic group (fig. 3), 
consistent with the theory that PGC-1α expression is stimulated during 
exercise, whereby it supports mitochondrial biogenesis to increase ATP 
production and provide energy.  
The results of research conducted by Finck (2007), indicate that 
PGC-1α plays an important role in controlling cardiac energy 
metabolism and suggest that perturbations in the PGC-1α system 
could influence to cardiomyopathic remodeling. PGC-1α 
overexpression prevented cardiac hypertrophy or improved 
contractility in cultured cardiac myocytes [7]. 
The results shown in fig. 3 indicated decreased PGC-1α expression in 
the OT rat group as a result of pathological cardiac hypertrophy, 
consistent with the results of Pereira et al. (2014) showing that 
during pathological hypertrophy, PGC-1α is repressed in concert 
with reduced mitochondrial oxidative capacity and FAO [8]. 
Notably, H. sabdariffa had no significant effects in the present study. 
This finding contrasts with an in vivo study conducted by Odigie et 
al. (2003) showing that water extract from HSL is potentially 
antihypertensive and cardioprotective with long-term 
administration at 250 mg/kg daily [18]. Thus, the cardioprotective 
effect of HSL is probably dependent on dose and duration of 
treatment, and should be examined in future studies. 
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